Renibus Therapeutics Receives FDA Fast Track Designation for RBT-9 Treatment in COVID-19
23 juin 2020 09h00 HE
|
Rénibus Therapeutics Inc.
DALLAS, Texas, June 23, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it has been granted Fast Track designation by the FDA for...